Does ROTIGOTINE Cause Therapeutic response shortened? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Therapeutic response shortened have been filed in association with ROTIGOTINE (Neupro). This represents 0.8% of all adverse event reports for ROTIGOTINE.
60
Reports of Therapeutic response shortened with ROTIGOTINE
0.8%
of all ROTIGOTINE reports
1
Deaths
7
Hospitalizations
How Dangerous Is Therapeutic response shortened From ROTIGOTINE?
Of the 60 reports, 1 (1.7%) resulted in death, 7 (11.7%) required hospitalization, and 3 (5.0%) were considered life-threatening.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROTIGOTINE. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does ROTIGOTINE Cause?
Product adhesion issue (1,718)
Off label use (646)
Drug ineffective (632)
Death (595)
Parkinson's disease (419)
Fall (412)
Device adhesion issue (383)
Overdose (353)
Application site pruritus (334)
Application site erythema (330)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
Which ROTIGOTINE Alternatives Have Lower Therapeutic response shortened Risk?
ROTIGOTINE vs ROXADUSTAT
ROTIGOTINE vs ROXICODONE
ROTIGOTINE vs ROXITHROMYCIN
ROTIGOTINE vs ROZANOLIXIZUMAB
ROTIGOTINE vs ROZANOLIXIZUMAB-NOLI